Stay updated on PC14586 in TP53 Y220C+ Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the PC14586 in TP53 Y220C+ Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PC14586 in TP53 Y220C+ Solid Tumors Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The change on the webpage possibly concerns the update in the Participation Criteria from 'Participation Criteria 6' to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria.' This change reflects modifications in the medical and healthcare-related criteria for individuals interested in participating in the clinical research study.
    Difference
    18%
    Check dated 2024-05-22T15:28:53.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    15 days ago
    Change Detected
    Summary
    The value (Estimated) has recently changed to . This change represents an update in the estimated primary completion date for the study involving the evaluation of PC14586 in patients with advanced solid tumors harboring a TP53 Y220C mutation.
    Difference
    0.0%
    Check dated 2024-05-10T08:54:14.000Z thumbnail image
  7. Check
    16 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 'Not yet recruiting' to 'Recruiting'. This change indicates that the site is now actively recruiting participants for the clinical trial.
    Difference
    2%
    Check dated 2024-05-09T06:31:54.000Z thumbnail image
  8. Check
    24 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2024-04-30T23:01:24.000Z thumbnail image

Stay in the know with updates to PC14586 in TP53 Y220C+ Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PC14586 in TP53 Y220C+ Solid Tumors Clinical Trial page.